SynopsisNeurodegenerative disease is caused by the loss of neurons and/or their myelin sheath, which worsens over time and becomes dysfunctional. The global Neurodegenerative Diseases Drug market was valued at US$ million in 2023 and is anticipated to reach US$.....
SynopsisThe global Pseudoephedrine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Pseudoephedrine is estimated to increase from $ mi.....
SynopsisGuaiphenesin is also known as Guaifenesin is an expectorant drug usually taken orally to assist the expectoration ('bringing up') of phlegm from the airways in acute respiratory tract infections. The global Guaiphenesin market was valued at US$ million i.....
SynopsisThe global Phenazone (Antipyrine) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Phenazone (Antipyrine) is estimated to incr.....
SynopsisA cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it .....
SynopsisThe global Flurbiprofen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Flurbiprofen is estimated to increase from $ million .....
SynopsisLoxoprofen is a propionic acid derivative non-steroidal anti-inflammatory drug. The global Loxoprofen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
SynopsisKetorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.It's analgesic properties make it a useful pain management tool across many settings including po.....
SynopsisIndometacin, or indomethacin, is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic properties. NSAIDs consist of agents that are structurally unrelated; the NSAID chemical classification of indometacin is an indo.....
SynopsisThe global Musculoskeletal Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growi.....
